Year Founded
2000
Ownership
Private
Employees
~100
Stage
Commercial
Modalities
Autologous cell therapy

Tetec General Information

Company specializes in biological cartilage regeneration through cell-based therapy innovations with over 20 years of experience

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Reutlingen,
Germany

Drug Pipeline

MACT
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Tetec's pipeline data

Book a demo

Key Partnerships

B. Braun, Aesculap

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Tetec Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Tetec's complete valuation and funding history, request access »

Tetec Investors

Octane Biotech
Investor Type: Venture Capital
Holding: Minority
Natural and Medical Sciences Institute
Investor Type: Venture Capital
Holding: Minority